SCHEMBL69910

SCHEMBL69910

CCC(C(=O)Cl)C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL656015 0.91 CHRM1 (0.36)
SCHEMBL30279 0.88
SCHEMBL8488441 0.85
SCHEMBL11568004 0.84
Pyridine SCHEMBL27438817 0.79 TSHR (0.38)
SCHEMBL286723 0.79 SMN1; SMN2 (0.42)
SCHEMBL2779128 0.79 ALDH1A1 (0.42)
SCHEMBL628200 0.75 TDP1 (0.43)
SCHEMBL176693 0.73
Ethylmalonate SCHEMBL107241 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2391 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118356812-A Ternary polymerization polyamide composite membrane and preparation method and application thereof 南京工业大学 2024-07-19 CN claimed
US-11286238-B2 Melatonin derivatives, method thereof, and use thereof Li, Yufei (CN) 2022-03-29 US claimed
US-20210323917-A1 MELATONIN DERIVATIVES, METHOD THEREOF, AND USE THEREOF XIAMEN NUOKANGDE BIOLOGICAL TECHNOLOGY CO., LTD. (CN) 2021-10-21 US claimed
CN-106749052-B Preparation method of clobazam 济南科汇医药科技有限公司 2020-09-01 CN claimed
CN-103788070-B The inhibitor class polymers of DPP 4 南京华威医药科技开发有限公司 2017-10-20 CN claimed
CN-106800519-A Ultrasonic radiation method Fast back-projection algorithm bridging type pair, the universal method of three, four amide derivatives and application 中南民族大学 2017-06-06 CN claimed
CN-103788070-A DPP-4 inhibitor polymer NANJING HUAWE MEDICAL TECHNOLOGY DEV CO LTD 2014-05-14 CN claimed
EP-0936218-B1 BENZIMIDAZOLE DERIVATIVES MOCHIDA PHARM CO LTD (JP) 2003-04-02 EP claimed
WO-2001020995-A9 COMPOUNDS DIRECTED AGAINST PILUS BIOGENESIS AND ACTIVITY IN PATHOGENIC BACTERIA; METHODS AND COMPOSITIONS FOR SYNTHESIS THEREOF UNIV WASHINGTON (US) 2002-11-14 WO claimed
US-6387938-B1 Benzimidazole derivatives MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 2002-05-14 US claimed
US-20020045751-A1 Thyromimetic organic compounds NOVARTIS AG (CH) 2002-04-18 US claimed
WO-2001020995-A1 COMPOUNDS DIRECTED AGAINST PILUS BIOGENESIS AND ACTIVITY IN PATHOGENIC BACTERIA; METHODS AND COMPOSITIONS FOR SYNTHESIS THEREOF WASHINGTON UNIVERSITY (US) 2001-03-29 WO claimed
EP-0936218-A1 NOVEL BENZIMIDAZOLE DERIVATIVES MOCHIDA PHARMACEUTICAL CO., LTD. (JP) 1999-08-18 EP claimed
EP-0440329-A1 S-substituted carbonyl substituted betathioacrylamide biocides and fungicides ROHM AND HAAS COMPANY (US) 1991-08-07 EP claimed
EP-0010426-A1 Pharmaceutical composition containing 3,4-dihydro-3-oxo-2-quinoxalines, novel such quinoxalines and processes for the production thereof ELI LILLY AND COMPANY (US) 1980-04-30 EP claimed
US-6423486-B1 None US disclosed
JP-9100267-A None JP disclosed
US-3976681-A DIURETIC, SALURETIC, URICOSURIC MERCK & CO., INC. (US) 1976-08-24 US disclosed
US-3966966-A DIURETICS MERCK & CO., INC. (US) 1976-06-29 US disclosed
US-3965118-A Lactone intermediates THE UPJOHN COMPANY (US) 1976-06-22 US disclosed